Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fenyo, EM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Losman, B; Bolmstedt, A; Schonning, K; Bjorndal, A; Westin, C; Fenyo, EM; Olofsson, S
      Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    2. Tscherning-Casper, C; Vodros, D; Menu, E; Aperia, K; Fredriksson, R; Dolcini, G; Chaouat, G; Barre-Sinoussi, F; Albert, J; Fenyo, EM
      Coreceptor usage of HIV-1 isolates representing different genetic subtypesobtained from pregnant Cameroonian women

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Tscherning-Casper, C; Dolcini, G; Mauclere, P; Fenyo, EM; Barre-Sinoussi, F; Albert, J; Menu, E
      Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    4. Lallos, LB; Cecilia, D; Fenyo, EM; Laal, S; Zolla-Pazner, S
      HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) classII in the virion envelope

      AIDS
    5. Lawoko, A; Johansson, B; Ljunggren, J; Fries, A; Fredriksson, R; Georgievska, L; Malmvall, B; Pipkorn, R; Fenyo, EM; Blomberg, J
      Structural prerequisites for intersubtype B and D antigenicity of the third variable envelope region (V3) of human immunodeficiency virus type 1

      JOURNAL OF INFECTIOUS DISEASES
    6. Jansson, M; Backstrom, E; Bjorndal, A; Holmberg, V; Rossi, P; Fenyo, EM; Popovic, M; Albert, J; Wigzell, H
      Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS

      JOURNAL OF HUMAN VIROLOGY
    7. Bjorndal, A; Sonnerborg, A; Tscherning, C; Albert, J; Fenyo, EM
      Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    8. Flore, JR; Buccoliero, G; Pezzotti, P; Rezza, G; Saracino, A; Pastore, G; Fenyo, EM; Angarano, G
      HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner

      AIDS
    9. Lawoko, AL; Johansson, B; Hjalmarsson, S; Christensson, B; Ljungberg, B; Al-Khalili, L; Sjolund, M; Pipkorn, R; Fenyo, EM; Blomberg, J
      Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera

      JOURNAL OF MEDICAL VIROLOGY
    10. Morner, A; Bjorndal, A; Albert, J; Kewalramani, VN; Littman, DR; Inoue, R; Thorstensson, R; Fenyo, EM; Bjorling, E
      Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage

      JOURNAL OF VIROLOGY
    11. Tscherning-Casper, C; Papadogiannakis, N; Anvret, M; Stolpe, L; Lindgren, S; Bohlin, AB; Albert, J; Fenyo, EM
      The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy

      JOURNAL OF VIROLOGY
    12. CORRIGAN GE; ALKHALILI L; MALMSTEN A; THORSTENSSON R; FENYO EM; KALLANDER CFR; GRONOWITZ JS
      DIFFERENCES IN REVERSE-TRANSCRIPTASE ACTIVITY VERSUS P24 ANTIGEN-DETECTION IN CELL-CULTURE, WHEN COMPARING A HOMOGENEOUS GROUP OF HIV TYPE-1 SUBTYPE-B VIRUSES WITH A HETEROGENEOUS GROUP OF DIVERGENT STRAINS

      AIDS research and human retroviruses
    13. TSCHERNING C; ALAEUS A; FREDRIKSSON R; BJORNDAL A; DENG HK; LITTMAN DR; FENYO EM; ALBERT J
      DIFFERENCES IN CHEMOKINE CORECEPTOR USAGE BETWEEN GENETIC SUBTYPES OFHIV-1

      Virology
    14. BERGER EA; DOMS RW; FENYO EM; KORBER BTM; LITTMAN DR; MOORE JP; SATTENTAU QJ; SCHUITEMAKER H; SODROSKI J; WEISS RA
      A NEW CLASSIFICATION FOR HIV-1

      Nature
    15. SCARLATTI G; TRESOLDI E; BJORNDAL A; FREDRIKSSON R; COLOGNESI C; DENG HK; MALNATI MS; PLEBANI A; SICCARDI AG; LITTMAN DR; FENYO EM; LUSSO P
      IN-VIVO EVOLUTION OF HIV-1 CORECEPTOR USAGE AND SENSITIVITY TO CHEMOKINE-MEDIATED SUPPRESSION

      Nature medicine
    16. FIORE JR; ZHANG YJ; BJORNDAL A; DISTEFANO M; ANGARANO G; PASTORE G; FENYO EM
      BIOLOGICAL CORRELATES OF HIV-1 HETEROSEXUAL TRANSMISSION

      AIDS
    17. ANDERSON R; BARRESINOUSSI F; BRADAC J; BURKE DS; ESSEX M; FENYO EM; GALVAOCASTRO B; HU DJ; JAFFE H; KARAMOV E; KUIKEN C; KUNANUSONT C; LAGA M; LOWER J; MASTRO T; MCCUTCHAN FE; OPIO A; PAULI G; SUTHERLAND D; SCHWARTLANDER B; DEVINCENZI I; VONBRIESEN H; WASI C; WEBER J; PIOT P; CARAEL M; OSMANOV S
      IMPLICATIONS OF HIV VARIABILITY FOR TRANSMISSION - SCIENTIFIC AND POLICY ISSUES

      AIDS
    18. ZHANG YJ; FADEEL B; HODARA V; FENYO EM
      INDUCTION OF APOPTOSIS BY PRIMARY HIV-1 ISOLATES CORRELATES WITH PRODUCTIVE INFECTION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      AIDS
    19. LEHNER T; BIBERFELD P; BOUCHER C; DARBYSHIRE J; FENYO EM; HEENEY JL; JAGER JC; LUNDGREN JD; NEWELL ML; ROSCH P; ROSSI P; VIRELIZIER JL
      EUROPEAN CONTRIBUTION TO THE SCIENCE, PREVENTION AND MANAGEMENT OF HIV-INFECTION

      Vaccine
    20. ZHANG YJ; FREDRIKSSON R; MCKEATING JA; FENYO EM
      PASSAGE OF HIV-1 MOLECULAR CLONES INTO DIFFERENT CELL-LINES CONFERS DIFFERENTIAL SENSITIVITY TO NEUTRALIZATION

      Virology
    21. RICHMOND JFL; MUSTAFA F; LU S; SANTORO JC; WENG J; OCONNELL M; FENYO EM; HURWITZ JL; MONTEFIORI DC; ROBINSON HL
      SCREENING OF HIV-1 ENV GLYCOPROTEINS FOR THE ABILITY TO RAISE NEUTRALIZING ANTIBODY USING DNA IMMUNIZATION AND RECOMBINANT VACCINIA VIRUS BOOSTING

      Virology
    22. MUSTAFA F; RICHMOND JFL; FERNANDEZLARSSON R; LU S; FREDRIKSSON R; FENYO EM; OCONNELL M; JOHNSON E; WENG JY; SANTORO JC; ROBINSON HL
      HIV-1 ENV GLYCOPROTEINS FROM 2 SERIES OF PRIMARY ISOLATES - REPLICATION PHENOTYPE AND IMMUNOGENICITY

      Virology
    23. BJORNDAL A; DENG HK; JANSSON M; FIORE JR; COLOGNESI C; KARLSSON A; ALBERT J; SCARLATTI G; LITTMAN DR; FENYO EM
      CORECEPTOR USAGE OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES VARIES ACCORDING TO BIOLOGICAL PHENOTYPE

      Journal of virology
    24. ZHANG YJ; FRACASSO C; FIORE JR; BJORNDAL A; ANGARANO G; GRINGERI A; FENYO EM
      AUGMENTED SERUM NEUTRALIZING ACTIVITY AGAINST PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ISOLATES IN 2 GROUPS OF HIV-1-INFECTED LONG-TERM NONPROGRESSORS

      The Journal of infectious diseases
    25. KONYA J; STUBER G; BJORNDAL A; FENYO EM; DILLNER J
      PRIMARY INDUCTION OF HUMAN CYTOTOXIC LYMPHOCYTES AGAINST A SYNTHETIC PEPTIDE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE

      Journal of General Virology
    26. SABRI F; CHIODI F; FENYO EM
      LACK OF CORRELATION BETWEEN V3 AMINO-ACID-SEQUENCE AND SYNCYTIUM-INDUCING CAPACITY OF SOME HIV TYPE-1 ISOLATES

      AIDS research and human retroviruses
    27. SCARLATTI G; LEITNER T; HODARA V; JANSSON M; KARLSSON A; WAHLBERG J; ROSSI P; UHLEN M; FENYO EM; ALBERT J
      INTERPLAY OF HIV-1 PHENOTYPE AND NEUTRALIZING ANTIBODY-RESPONSE IN PATHOGENESIS OF AIDS

      Immunology letters
    28. FENYO EM; PUTKONEN P
      BROAD CROSS-NEUTRALIZING ACTIVITY IN SERUM IS ASSOCIATED WITH SLOW PROGRESSION AND LOW-RISK OF TRANSMISSION IN PRIMATE LENTIVIRUS INFECTIONS

      Immunology letters
    29. PALMER C; BALFE P; FOX D; MAY JC; FREDERIKSSON R; FENYO EM; MCKEATING JA
      FUNCTIONAL-CHARACTERIZATION OF THE V1V2 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Virology
    30. MCKEATING JA; ZHANG YJ; ARNOLD C; FREDERIKSSON R; FENYO EM; BALFE P
      CHIMERIC VIRUSES EXPRESSING PRIMARY ENVELOPE GLYCOPROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SHOW INCREASED SENSITIVITY TO NEUTRALIZATION BY HUMAN SERA

      Virology
    31. TAN W; SCHALLING M; ZHAO CP; LUUKKONEN M; NILSSON M; FENYO EM; PAVLAKIS GN; SCHWARTZ S
      INHIBITORY ACTIVITY OF THE EQUINE INFECTIOUS-ANEMIA VIRUS MAJOR 5'-SPLICE-SITE IN THE ABSENCE OF REV

      Journal of virology
    32. WEBER J; FENYO EM; BEDDOWS S; KALEEBU P; BJORNDAL A; OSMANOV S; HEYWARD W; ESPARZA J; GALVAOCASTRO B; VANDEPERRE P; KARITA E; WASI C; SEMPALA S; TUGUME B; BIRYAHWAHO B; RUBSAMENWAIGMANN H; VONBRIESEN H; ESSER R; GREZ M; HOLMES H; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; HAHN BH; GAO F; YUE L; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; CHEINGSONGPOPOV R; NARA P; ALBERT J; MYERS G; KORBER B
      NEUTRALIZATION SEROTYPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FIELDISOLATES ARE NOT PREDICTED BY GENETIC SUBTYPE

      Journal of virology
    33. KARLSSON A; PARSMYR K; APERIA K; SANDSTROM E; FENYO EM; ALBERT J
      BIOLOGICAL PHENOTYPE OF HIV-1 ISOLATES AS A MARKER FOR RESPONSE TO TREATMENT AND DEVELOPMENT OF DRUG-RESISTANCE

      Journal of acquired immune deficiency syndromes and human retrovirology
    34. GRUNOW R; FRANKE L; HINKULA J; WAHREN B; FENYO EM; JONDAL M; VONBAEHR R
      MONOCLONAL-ANTIBODIES TO P24-CORE PROTEIN OF HIV-1 MEDIATE ADCC AND INHIBIT VIRUS SPREAD IN-VITRO

      Clinical and diagnostic virology
    35. FENYO EM; MCKEATING J; ZHANG YJ; FREDRIKSSON R; KATINGER H; BALFE P
      CHIMERIC VIRUSES CARRYING ENVELOPE GP120 FROM A PRIMARY HIV-1 ISOLATESHOW INCREASED SENSITIVITY TO NEUTRALIZATION BY HUMAN SERA

      AIDS research and human retroviruses
    36. SCARLATTI G; HODARA V; COLOGNESI C; BERETTA A; ALBERT J; FENYO EM
      AUTOLOGOUS NEUTRALIZING ANTIBODY-RESPONSE AND VIRUS PHENOTYPE IN PROGRESSION OF DISEASE OF HIV-1-INFECTED CHILDREN

      Journal of cellular biochemistry
    37. FENYO EM
      HIV BIOLOGICAL PHENOTYPE - PROGNOSIS MARKER FOR TRANSMISSION, DISEASEPROGRESSION AND THERAPY

      Journal of biological regulators and homeostatic agents
    38. AIUTI F; BOUCHER C; DIANZANI F; FENYO EM; HO D; LANE C; LANGE J; MONTANER J; PANTALEO G; PERRIN L; ROMAGNANI S; SAAG M; SCHOOLEY R; VELLA S
      CONSENSUS CONFERENCE ON LABORATORY MARKERS IN HIV-INFECTION - CONSENSUS CONCLUSIONS

      Journal of biological regulators and homeostatic agents
    39. ALBERT J; FIORE J; FENYO EM; PEDERSEN C; LUNDGREN JD; GERSTOFT J; NIELSEN C
      BIOLOGICAL PHENOTYPE OF HIV-1 AND TRANSMISSION

      AIDS
    40. LUUKKONEN BGM; FENYO EM; SCHWARTZ S
      OVEREXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INCREASES INTRACELLULAR CLEAVAGE OF GAG AND REDUCES VIRUS INFECTIVITY

      Virology
    41. LUUKKONEN BGM; TAN W; FENYO EM; SCHWARTZ S
      ANALYSIS OF CROSS-REACTIVITY OF RETROVIRUS PROTEASES USING A VACCINIAVIRUS T7 RNA POLYMERASE-BASED EXPRESSION SYSTEM

      Journal of General Virology
    42. YEFENOF E; MAGYARLAKI T; FENYO EM; WAHREN B; KLEIN E
      ALTERNATIVE COMPLEMENT PATHWAY ACTIVATION BY CD4-CELLS OF HIV-INFECTED INDIVIDUALS - A POSSIBLE ROLE IN AIDS PATHOGENESIS( T)

      International immunology
    43. OSMANOV S; BELSEY EM; HEYWARD W; ESPARZA J; GALVAOCASTRO B; VANDEPERRE P; KARITA E; WASI C; SEMPALA S; TUGUME B; BIRYAHWAHO B; RUBSAMENWAIGMANN H; VONBRIESEN H; ESSER R; GREZ M; HOLMES H; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; HAHN BH; GAO F; YUE L; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; WEBER J; CHEINGSONGPOPOV R; KALEEBU P; NARA P; FENYO EM; ALBERT J; MYERS G; KORBER B
      HIV TYPE-1 VARIATION IN WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENETIC SCREENING, SEQUENCE-ANALYSIS, AND PRELIMINARY BIOLOGICAL CHARACTERIZATION OF SELECTED VIRAL STRAINS

      AIDS research and human retroviruses
    44. KORBER BTM; OSMANOV S; ESPARZA J; MYERS G; BELSEY EM; HEYWARD W; GALVAOCASTRO B; VANDEPERRE P; KARITA E; WASI C; SEMPALA S; TUGUME B; BIRYAHWAHO B; RUBSAMENWAIGMANN H; VONBRIESEN H; ESSER R; GREZ M; HOLMES H; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; HAHN BH; GAO F; YUE L; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; WEBER J; CHEINGSONGPOPOV R; KALEEBU P; NARA P; FENYO EM; ALBERT J; KORBER B
      THE WORLD-HEALTH-ORGANIZATION GLOBAL PROGRAM ON AIDS PROPOSAL FOR STANDARDIZATION OF HIV SEQUENCE NOMENCLATURE

      AIDS research and human retroviruses
    45. GAO F; YUE L; CRAIG S; THORNTON CL; ROBERTSON DL; MCCUTCHAN FE; BRADAC JA; SHARP PM; HAHN BH; OSMANOV S; BELSEY EM; HEYWARD W; ESPARZA J; GALVAOCASTRO B; VANDEPERRE P; KARITA E; WASI C; SEMPALA S; TUGUME B; BIRYAHWAHO B; RUBSAMENWAIGMANN H; VONBRIESEN H; ESSER R; GREZ M; HOLMES H; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; WEBER J; CHEINGSONGPOPOV R; KALEEBU P; NARA P; FENYO EM; ALBERT J; MYERS G; KORBER B
      GENETIC-VARIATION OF HIV TYPE-1 IN 4 WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENERATION OF FUNCTIONAL ENVELOPE (GLYCOPROTEIN-160) CLONES REPRESENTATIVE OF SEQUENCE SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E

      AIDS research and human retroviruses
    46. PAU CP; KAI M; HOLLOMANCANDAL DL; LUO CC; KALISH ML; SCHOCHETMAN G; BYERS B; GEORGE JR; OSMANOV S; BELSEY EM; HEYWARD W; ESPARZA J; GALVAOCASTRO B; VANDEPERRE P; KARITA E; WASI C; SEMPALA S; TUGUME B; BIRYAHWAHO B; RUBSAMENWAIGMANN H; VONBRIESEN H; ESSER R; GREZ M; HOLMES H; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; HAHN BH; GAO F; YUE L; SARAGOSTI S; KALISH M; GEORGE R; WEBER J; CHEINGSONGPOPOV R; KALEEBU P; NARA P; FENYO EM; ALBERT J; MYERS G; KORBER B
      ANTIGENIC VARIATION AND SEROTYPING OF HIV TYPE-1 FROM 4 WORLD-HEALTH-ORGANIZATION-SPONSORED HIV VACCINE SITES

      AIDS research and human retroviruses
    47. CHEINGSONGPOPOV R; LISTER S; CALLOW D; KALEEBU P; BEDDOWS S; WEBER J; OSMANOV S; BELSEY EM; HEYWARD W; ESPARZA J; GALVAOCASTRO B; VANDEPERRE P; KARITA E; WASI C; SEMPALA S; TUGUME B; BIRYAHWAHO B; RUBSAMENWAIGMANN H; VONBRIESEN H; ESSER R; GREZ M; HOLMES H; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; HAHN BH; GAO F; YUE L; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; NARA P; FENYO EM; ALBERT J; MYERS G; KORBER B
      SEROTYPING HIV TYPE-1 BY ANTIBODY-BINDING TO THE V3 LOOP - RELATIONSHIP TO VIRAL GENOTYPE

      AIDS research and human retroviruses
    48. DEWOLF F; HOGERVORST E; GOUDSMIT J; FENYO EM; RUBSAMENWAIGMANN H; HOLMES H; GALVAOCASTRO B; KARITA E; WASI C; SEMPALA SDK; BAAN E; ZORGDRAGER F; LUKASHOV V; OSMANOV S; KUIKEN C; CORNELISSEN M; BELSEY EM; HEYWARD W; ESPARZA J; VANDEPERRE P; SEMPALA S; TUGUME B; BIRYAHWAHO B; VONBRIESEN H; ESSER R; GREZ M; NEWBERRY A; RANJBAR S; TOMLINSON P; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; HAHN BH; GAO F; YUE L; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; WEBER J; CHEINGSONGPOPOV R; KALEEBU P; NARA P; ALBERT J; MYERS G; KORBER B
      SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING CAPACITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUBTYPES OTHER THAN B - PHENOTYPIC AND GENOTYPIC CHARACTERISTICS

      AIDS research and human retroviruses
    49. RUBSAMENWAIGMANN H; VONBRIESEN H; HOLMES H; BJORNDAL A; KORBER B; ESSER R; RANJBAR S; TOMLINSON P; GALVAOCASTRO B; KARITA E; SEMPALA S; WASI C; OSMANOV S; FENYO EM; BELSEY EM; HEYWARD W; ESPARZA J; VANDEPERRE P; TUGUME B; BIRYAHWAHO B; GREZ M; NEWBERRY A; BRADAC J; MCCUTCHAN F; LOUWAGIE J; HEGERICH P; LOPEZGALINDEZ C; OLIVARES I; DOPAZO J; MULLINS JI; DELWART EL; BACHMANN HM; GOUDSMIT J; DEWOLF F; HAHN BH; GAO F; YUE L; SARAGOSTI S; SCHOCHETMAN G; KALISH M; LUO CC; GEORGE R; PAU CP; WEBER J; CHEINGSONGPOPOV R; KALEEBU P; NARA P; ALBERT J; MYERS G
      STANDARD CONDITIONS OF VIRUS ISOLATION REVEAL BIOLOGICAL VARIABILITY OF HIV TYPE-1 IN DIFFERENT REGIONS OF THE WORLD

      AIDS research and human retroviruses
    50. SCARLATTI G; LEITNER T; HALAPI E; ROSSI P; ALBERT J; FENYO EM
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION FROM MOTHER-TO-CHILD- MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF TRANSMITTED VIRUS

      AIDS research and human retroviruses
    51. FENYO EM
      ANTIGENIC VARIATION OF PRIMATE LENTIVIRUSES IN HUMANS AND EXPERIMENTALLY INFECTED MACAQUES

      Immunological reviews
    52. KARLSSON A; PARSMYR K; SANDSTROM E; FENYO EM; ALBERT J
      MT-2 CELL TROPISM AS PROGNOSTIC MARKER FOR DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      Journal of clinical microbiology
    53. FIORE JR; BJORNDAL A; PEIPKE KA; DISTEFANO M; ANGARANO G; PASTORE G; GAINES H; FENYO EM; ALBERT J
      THE BIOLOGICAL PHENOTYPE OF HIV-1 IS USUALLY RETAINED DURING AND AFTER SEXUAL TRANSMISSION

      Virology
    54. ZHANG YJ; PUTKONEN P; ALBERT J; OHMAN P; BIBERFELD G; FENYO EM
      STABLE BIOLOGICAL AND ANTIGENIC CHARACTERISTICS OF HIV-2(SBL6669) IN NONPATHOGENIC INFECTION OF MACAQUES

      Virology
    55. ALGAZI M; ANCELLEPARK R; ASJO B; BARIN F; BARME M; BARRESINOUSSI F; BAYLON H; BENICHOU J; BENICHOU G; BEZEAUD A; BLANCHER A; BLATTNER WA; BLOT P; BOURROUILLOU G; BOUTTIER D; BOVEN B; BRUNET JB; CADROY Y; CAEN J; CAHAN C; CALVAS P; CARANOBE C; CARRELL RW; CHANZY M; CHAOUAT G; CHIODI F; COLOMBIES P; COUTINHO A; DAUSSET J; DEVINCENTI I; DEBRE P; DENIS F; DESMYTER J; DEUBEL V; DEVERGIE A; DODIN A; DORE JF; DREYFUS JC; DREYFUSBRISAC C; DUCOS J; DURAND H; FENYO EM; FLEURY H; FOURNEL JJ; FROTTIER J; GAILLARD J; GALANAUD P; GARCON P; GAZZOLO L; GEORGES AJ; GEORGESCOURBOT MC; GIRARD M; GLUCKMAN E; GLUCKMAN JC; GOLDBERG M; GOUBAU P; GUILLIN MC; HERRAULT A; JENNINGS M; JUHANVAGUE I; KANKI PJ; KAZATCHKINE M; KIRN A; KLATZMANN D; KOHEN JP; KREIS H; KRUH J; LEMINOR L; LESOURD G; LIDEREAU R; LORTHOLARY P; LOWENSTEIN W; LOYGUE J; MARCOVICH H; MARTY M; MATHIOT C; MONODBROCA P; ORTH G; DASILVA LP; PERES G; PILLOT J; POLICARD C; REYNES J; ROZENBAUM W; SCARLATTI G; SCHAISON G; SCHUPBACH J; SIE P; SMILOVICI W; SOURNIA JC; TARANTOLA D; TAVITIAN A; TEDGUI A; TESTAS P; TIOLLAIS P; ULLMAN A; WOLLMAN E; WOLLMAN A
      APPEAL TO MITTERRAND IN BLOOD SCANDAL

      Nature
    56. VALENTIN A; ALBERT J; FENYO EM; ASJO B
      DUAL TROPISM FOR MACROPHAGES AND LYMPHOCYTES TS A COMMON FEATURE OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 ISOLATES

      Journal of virology
    57. KARLSSON A; PARSMYR K; APERIA K; SANDSTROM E; FENYO EM; ALBERT J
      MT-2 CELL TROPISM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES AS A MARKER FOR RESPONSE TO TREATMENT AND DEVELOPMENT OF DRUG-RESISTANCE

      The Journal of infectious diseases
    58. FENYO EM; ZHANG YJ; BJORLING E; SCARLATTI G
      BIOLOGICAL AND ANTIGENIC VARIATION OF PRIMATE LENTIVIRUSES IN HUMANS AND IN EXPERIMENTALLY INFECTED MACAQUES

      Journal of acquired immune deficiency syndromes
    59. ASJO B; KORNEYEVA M; VOJKOVIC A; ALBERT J; ESPEJO R; FENYO EM
      THE BLOCKING OF SLOW LOW TYPE HIV REPLICATION IN CD4-LINES TAKES PLACE AFTER PROVIRUS FORMATION( CELL)

      Journal of acquired immune deficiency syndromes
    60. VONGEGERFELT A; DIAZPOHL C; FENYO EM; BROLIDEN K
      SPECIFICITY OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-INFECTED INDIVIDUALS

      AIDS research and human retroviruses
    61. ALBERT J; BJORLING E; VONGEGERFELT A; SCARLATTI G; ZHANG YJ; FENYO EM; THORSTENSSON R
      ANTIGEN-DETECTION IS A RELIABLE METHOD FOR EVALUATING HIV SIV NEUTRALIZATION ASSAYS

      AIDS research and human retroviruses
    62. TAN W; FREDRIKSSON R; BJORNDAL A; BALFE P; FENYO EM
      COTRANSFECTION OF HIV-1 MOLECULAR CLONES WITH RESTRICTED CELL TROPISMMAY YIELD PROGENY VIRUS WITH ALTERED PHENOTYPE

      AIDS research and human retroviruses
    63. SCARLATTI G; HODARA V; ALBERT J; ROSSI P; FENYO EM
      MOTHER-TO-CHILD TRANSMISSION OF HIV-1 - BIOLOGICAL PROPERTIES OF THE VIRUS AND THE MATERNAL NEUTRALIZING ANTIBODY-RESPONSE

      AIDS research and human retroviruses
    64. LEITNER T; HALAPI E; SCARLATTI G; ROSSI P; ALBERT J; FENYO EM; UHLEN M
      ANALYSIS OF HETEROGENEOUS VIRAL POPULATIONS BY DIRECT DNA-SEQUENCING

      BioTechniques
    65. SCARLATTI G; LEITNER T; HALAPI E; ROSSI P; ALBERT I; FENYO EM
      MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF HIV-1 FROM 10 MOTHER-CHILD PAIRS

      Journal of cellular biochemistry
    66. ZHANG Y; PUTKONEN P; ALBERT J; FENYO EM
      BIOLOGICAL AND ANTIGENIC PROPERTIES OF SEQUENTIAL REISOLATES FROM MACAQUES EXPERIMENTALLY INFECTED WITH HIV-2

      Journal of cellular biochemistry
    67. VONGEGERFELT A; PUTKONEN P; FENYO EM; BROLIDEN K
      ADCC IN HIV-2 SIVMAC INFECTED INDIVIDUALS AND OR IMMUNIZED MONKEYS/

      Journal of cellular biochemistry
    68. LEITNER T; HALAPI E; SCARLATTI G; ROSSI P; ALBERT J; FENYO EM
      ANALYSIS OF HETEROGENEOUS VIRAL POPULATIONS BY DIRECT GENOMIC SEQUENCING

      Journal of cellular biochemistry
    69. FENYO EM
      VIRAL PHENOTYPE AND SEVERITY OF HIV-1 INFECTION - ARE CHILDREN DIFFERENT FROM ADULTS

      AIDS
    70. SCARLATTI G; LEITNER T; HODARA V; HALAPI E; ROSSI P; ALBERT J; FENYO EM
      NEUTRALIZING ANTIBODIES AND VIRAL CHARACTERISTICS IN MOTHER-TO-CHILD TRANSMISSION OF HIV-1

      AIDS
    71. ZHANG YJ; OHMAN P; PUTKONEN P; ALBERT J; WALTHER L; STALHANDSKE P; BIBERFELD G; FENYO EM
      AUTOLOGOUS NEUTRALIZING ANTIBODIES TO SIV(SM) IN CYNOMOLGUS MONKEYS CORRELATE TO PROGNOSIS

      Virology
    72. SCARLATTI G; HODARA V; ROSSI P; MUGGIASCA L; BUCCERI A; ALBERT J; FENYO EM
      TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) FROM MOTHER-TO-CHILD CORRELATES WITH VIRAL PHENOTYPE

      Virology
    73. SCARLATTI G; ALBERT J; ROSSI P; HODARA V; BIRAGHI P; MUGGIASCA L; FENYO EM
      MOTHER-TO-CHILD TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 -CORRELATION WITH NEUTRALIZING ANTIBODIES AGAINST PRIMARY ISOLATES

      The Journal of infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 15:10:55